- Home
- SAGE vs ASC Comparison
SAGE vs ASC Comparison
Compare SAGE & ASC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- ASC
- Stock Information
- Founded
- SAGE 2010
- ASC 2010
- Country
- SAGE United States
- ASC Bermuda
- Employees
- SAGE N/A
- ASC N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- ASC Marine Transportation
- Sector
- SAGE Health Care
- ASC Consumer Discretionary
- Exchange
- SAGE Nasdaq
- ASC Nasdaq
- Market Cap
- SAGE 474.6M
- ASC 411.3M
- IPO Year
- SAGE 2014
- ASC 2013
- Fundamental
- Price
- SAGE $7.77
- ASC $9.66
- Analyst Decision
- SAGE Hold
- ASC Buy
- Analyst Count
- SAGE 19
- ASC 3
- Target Price
- SAGE $9.88
- ASC $18.00
- AVG Volume (30 Days)
- SAGE 1.2M
- ASC 608.0K
- Earning Date
- SAGE 04-24-2025
- ASC 05-07-2025
- Dividend Yield
- SAGE N/A
- ASC 9.83%
- EPS Growth
- SAGE N/A
- ASC 12.91
- EPS
- SAGE N/A
- ASC 3.06
- Revenue
- SAGE $41,243,000.00
- ASC $405,784,000.00
- Revenue This Year
- SAGE $100.39
- ASC N/A
- Revenue Next Year
- SAGE $70.86
- ASC N/A
- P/E Ratio
- SAGE N/A
- ASC $3.19
- Revenue Growth
- SAGE N/A
- ASC 2.48
- 52 Week Low
- SAGE $4.62
- ASC $8.83
- 52 Week High
- SAGE $17.51
- ASC $23.44
- Technical
- Relative Strength Index (RSI)
- SAGE 48.49
- ASC 40.62
- Support Level
- SAGE $7.99
- ASC $9.80
- Resistance Level
- SAGE $8.81
- ASC $10.23
- Average True Range (ATR)
- SAGE 0.31
- ASC 0.28
- MACD
- SAGE -0.06
- ASC 0.01
- Stochastic Oscillator
- SAGE 9.57
- ASC 11.11
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.